Free US stock valuation multiples and PEG ratio analysis to identify reasonably priced growth companies with attractive risk-reward profiles. Our valuation framework helps you find stocks with the right balance of growth and value characteristics for your portfolio. We provide P/E analysis, PEG ratios, and relative valuation metrics for comprehensive valuation coverage. Find value in growth with our comprehensive valuation analysis and multiples tools for growth at a reasonable price strategies.
Arcadia Biosciences Inc. (RKDA), an agricultural biotechnology firm focused on sustainable crop solutions, is trading at $1.31 as of April 7, 2026, marking a 1.13% decline on the day. This analysis evaluates key technical levels, recent market context, and potential price scenarios for RKDA amid current market conditions. No recent earnings data is available for the company at this time, so near-term price action is largely being driven by technical flows, sector sentiment, and broader small-cap
What is the volatility of Arcadia Biosciences (RKDA) Stock | Price at $1.31, Down 1.13% - Elite Alerts
RKDA - Stock Analysis
3912 Comments
627 Likes
1
Daleon
Regular Reader
2 hours ago
Innovation at its peak! 🚀
👍 112
Reply
2
Shivana
Legendary User
5 hours ago
This feels like a glitch in real life.
👍 257
Reply
3
Quwana
Expert Member
1 day ago
Really helpful breakdown, thanks for sharing!
👍 124
Reply
4
Margia
Consistent User
1 day ago
As a working mom, timing like this really matters… missed it.
👍 145
Reply
5
Rockney
Experienced Member
2 days ago
I feel like there’s a hidden group here.
👍 75
Reply
Disclaimer: Not investment advice. For informational purposes only. Past performance does not guarantee future results. Trading involves substantial risk of loss.